US Patent Issued to ASCENTAWITS PHARMACEUTICALS on Aug. 4 for "Orally administered solid dosage form drug" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,697,306, issued on Aug. 4, was assigned to ASCENTAWITS PHARMACEUTICALS LTD. (Shenzhen, China).

"Orally administered solid dosage form drug" was invented by Jianxin Duan (Shenzhen, China) and Anrong Li (Shenzhen, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "An orally administered solid dosage form comprising a drug for treating cancers, tumors or cell proliferative disorders contains a compound of the following structural formula I or II."

The patent was filed on Oct. 30, 2020, under Application No. 17/773,339.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=...